combination of ACE inhibitor/angiotension 2 receptor antagonist

From Aaushi
Jump to navigation Jump to search

Introduction

Randomized, double-blind, cross-over trial

Study:

Results:

More general terms

Components

References

  1. Journal Watch 23(13):107, 2003 Jacobson P et al, Kidney Int 63:1874, 2003 Thurman JM & Schrier RW, Am J Med 114:588, 2003 Rosner MH & Okusa MD, Arch Intern Med 163:1025, 2003